2-79086832-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000305089.8(REG1B):c.163G>A(p.Glu55Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000305089.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
REG1B | NM_006507.4 | c.163G>A | p.Glu55Lys | missense_variant | 3/6 | ENST00000305089.8 | NP_006498.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
REG1B | ENST00000305089.8 | c.163G>A | p.Glu55Lys | missense_variant | 3/6 | 1 | NM_006507.4 | ENSP00000303206.3 | ||
REG1B | ENST00000476554.1 | n.268G>A | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
REG1B | ENST00000479258.5 | n.270G>A | non_coding_transcript_exon_variant | 3/4 | 1 | |||||
REG1B | ENST00000454188.5 | c.16G>A | p.Glu6Lys | missense_variant | 1/4 | 3 | ENSP00000387410.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152042Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251218Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135766
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461810Hom.: 0 Cov.: 33 AF XY: 0.0000248 AC XY: 18AN XY: 727218
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152160Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.163G>A (p.E55K) alteration is located in exon 3 (coding exon 2) of the REG1B gene. This alteration results from a G to A substitution at nucleotide position 163, causing the glutamic acid (E) at amino acid position 55 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at